It has been shown that B-ALL is associated with loss of CD8+ T cells, as indicated by a significantly lower frequencies of CD8+ T cells in the patients’ bone marrow compared to healthy controls, together with accumulation of late stage effector CD4+ T cells [73]. Here, CD8A is linked to acute lymphoblastic leukemia.